195 related articles for article (PubMed ID: 1433900)
1. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
Uete T; Matsuo K; Uete G
Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. II. Isolation of arbekacin-resistant strain.
Inouye Y; Morifuji K; Masumi N; Nakamura S; Takesue Y; Santou T; Yokoyama T
Hiroshima J Med Sci; 1992 Dec; 41(4):79-85. PubMed ID: 1293073
[TBL] [Abstract][Full Text] [Related]
4. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents.
Sowa S; Masumi N; Inouye Y; Nakamura S; Takesue Y; Yokoyama T
Hiroshima J Med Sci; 1991 Dec; 40(4):137-44. PubMed ID: 1797744
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of MICs on 16 antimicrobial agents for freshly isolated methicillin-resistant Staphylococcus aureus strains].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y
Jpn J Antibiot; 1990 Apr; 43(4):623-35. PubMed ID: 2381034
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activity of various antibacterial agents against methicillin-resistant Staphylococcus aureus, and difference in antibacterial activity between aminoglycosides by coagulase type. Comparison of isolates obtained in the period from 1982 to 1986 and isolates in recent 6 months].
Wada K; Kawasima T; Arakawa M; Ozaki K
Jpn J Antibiot; 1990 Feb; 43(2):219-27. PubMed ID: 2362349
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activity of tosufloxacin against fresh clinical isolates].
Yamashiro Y; Shimakura M; Minami S; Fukuoka Y; Yasuda T; Watanabe Y; Narita H; Akama M
Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T
Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
15. Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections.
Nishijima S; Namura S; Akamatsu H; Kawai S; Asada Y; Kawabata S; Fujita M
J Dermatol; 1995 Feb; 22(2):153-5. PubMed ID: 7722093
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
17. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
19. [Aminoglycosides resistance of methicillin-resistant Staphylococcus aureus].
Okamoto R; Okubo T
Nihon Rinsho; 1992 May; 50(5):1036-41. PubMed ID: 1324330
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
